Dave

[Vinay Prasad MD MPH @VPrasadMDMPH]

Dave A. is a M4 at @IcahnMountSinai
He came to @UCSF_Epibiostat in Oct
We wrote this paper then, which appears now in @JAMA_current
Its about a wild drug approval
Zuranalone for postpartum depression
🧵
& Interested Students can rotate here w me
email
https://t.co/saGeqGSvEm

[Vinay Prasad MD MPH @VPrasadMDMPH]

Amazing post by @DaveKnave3 on @Sensible__Med
He explains the evidence for RSV vax for Pregnant women and open safety question
Great essay!! @drjohnm
https://t.co/WRa4ulcL6I

[Dave @DaveKnave3]

@Lpa_Doc Interesting, this is the case for all LDL-C and apoB discordance? Would love a link to paper or papers that show this.

[Dave @DaveKnave3]

@EricTopol @TheLancetInfDis Doesnt the massive difference at time zero pretty clearly show this is a fundamentally biased comparison of groups? Seems odd to share this figure without acknowledging the elephant at the origin.

[Dave @DaveKnave3]

@Skeptic77207158 Definitely agree this study is not the final word on boosters or anything else and must be taken for what it is (observational, short duration, etc.) but I appreciated the discussion provided by the authors.

[Dave @DaveKnave3]

@EricTopol This graph seems to make a strong case that boosting has modest added benefit beyond primary series even in >50 y/o. Two boosters reduce the incidence of death by 1 person in 100,000, and that is before considering how much of this is behavioral, etc, not due to the vaccine.

[Dave @DaveKnave3]

@Drlipid If you could redesign the basic lipid panel/tests that are run in primary care clinics to screen for risks, what is the comprehensive list of what you would add? (also what would you remove)